Elmer Llanos-Cuentas in Proceedings of International Conference on Plasmodium vivax

Papers 3

Tafenoquine for radical cure of Plasmodium vivax malaria: a randomized, double-blind, double-dummy, comparative, multicenter Phase III study (“GATHER”).
Achieving Universal access to safe and radical cure

Marcus Vinícius Guimarães de Lacerda ¹ ; Elmer Llanos-Cuentas ² ; Cindy Chu ³ ; Tran T. Hien ⁴ ; Chaiado Namaik-Larp ⁵ ; Maria F. Villegas ⁶ ; Ivan D. Velez ⁷ ; Stephan Duparc ⁸ ; Sion W. Jones ⁹ ; Elizabeth Hardaker ⁹ ; Khadeeja Mohamed ⁹ ; Gavin CKW Koh ⁹ ; Jutin A Green ⁹ ; Viviana Wilches ¹⁰ ; John Breton ¹⁰

¹ Fundação de Medicina Tropical do Amazonas, Brazil ;

² Universidad Peruana Cayetano Heredia, Lima, Peru ;

³ Shoklo Malaria Research Unit, Thailand ;

⁴ Oxford University Clinical Research Unit, Vietnam ;

⁵ Umphang Hospital, Thailand ;

⁶ Centro de investigaciones Clinicas SAS, Colombia ;

⁷ PECET, Universidad de Antioquia, Medellin, Colombia ;

⁸ Medicines for Malaria Venture, Switzerland ;

⁹ GlaxoSmithKline, United Kingdom ;

¹⁰ GlaxoSmithKline, USA

Vol.1, 2017 -
63245
Multiplicity of infection and parasite load of Plasmodium vivax in individuals with recurrences of the communities of cahuide and lupuna of the Peruvian Amazon
Epidemiology and surveillance

Jhonatan Jesus Alarcon Baldeon ¹ ; Oscar Nolasco Cárdenas ¹ ; Paulo Manrique Valverde ¹ ; Gabriel Carrasco Escobar ¹ ; Mitchel Guzmán ¹ ; Elmer Llanos Cuentas ² ; Joseph Vinetz ³ ; Dionicia Gamboa Vilela ¹

¹ Laboratorio de Malaria, Laboratorios de investigación y desarrollo, Facultad de Ciencias y Filosofía, Universidad Peruana Cayetano Heredia, Lima, Perú ;

² Instituto de Medicina Tropical Alexander von Humboldt, Lima, Perú ;

³ University of California San Diego, San Diego, CA, United States.

Vol.1, 2017 -
63169
Tafenoquine for radical cure of Plasmodium vivax malaria: a multicentre, randomised, double-blind, placebo-controlled phase III trial (“DETECTIVE”).
Achieving Universal access to safe and radical cure

Elmer Llanos-Cuentas ¹ ; Marcus Vinícius Guimarães de Lacerda ² ; Raul Chuquiyauri ¹ ; David Saunders ³ ; Lon Chanthap ³ ; Daniel Yilma ⁴ ; Rezika Mohammed ⁵ ; Srivicha Krudsood ⁶ ; Dhelio Pereira ⁷ ; Fe Espino ⁸ ; Harald Noedl ⁹ ; Brian Angus ¹⁰ ; Joerg-Peter Kleim ¹¹ ; Stephan Duparc ¹² ; Sion W. Jones ¹¹ ; Elizabeth Hardaker ¹¹ ; Khadeeja Mohamed ¹¹ ; Kim Fletcher ¹¹ ; Jhon Breton ¹³ ; Jutin A Green ¹¹ ; Cletus O. Ugwuegbulam ¹¹ ; Gavin CKW Koh ¹¹

¹ Universidad Peruana Cayetano Heredia, Lima, Peru ;

² Instituto Leonidas e Maria Deane, Fiocruz, Manaus, Brazil ;

³ Armed Forces Research Institute of Medical Sciences, Thailand ;

⁴ Jimma University, Ethiopia ;

⁵ University of Gondar, Ethiopia ;

⁶ Mahidol University, Thailand ;

⁷ Centro de Pesquisa em Medicina Tropical de Rondonia, Brazil ;

⁸ Research Institute for Tropical Medicine, Philippines ;

⁹ University of Vienna, Austria ;

¹⁰ University of Oxford, United Kingdom ;

¹¹ GlaxoSmithKline, United Kingdom ;

¹² Medicines for Malaria Venture, Switzerland ;

¹³ GlaxoSmithKline, USA

Vol.1, 2017 -
63246

Proceedings of International Conference on Plasmodium vivax

Elmer Llanos-Cuentas

Tafenoquine for radical cure of Plasmodium vivax malaria: a randomized, double-blind, double-dummy, comparative, multicenter Phase III study (“GATHER”).

Multiplicity of infection and parasite load of Plasmodium vivax in individuals with recurrences of the communities of cahuide and lupuna of the Peruvian Amazon

Tafenoquine for radical cure of Plasmodium vivax malaria: a multicentre, randomised, double-blind, placebo-controlled phase III trial (“DETECTIVE”).

Co-authors (35)

Marcus Vinícius Guimarães de Lacerda

Stephan Duparc

Gavin CKW Koh

Jutin A Green

Gabriel Carrasco Escobar

Khadeeja Mohamed

Elizabeth Hardaker

Sion W. Jones

David Saunders

Rezika Mohammed

Daniel Yilma

Dhelio Pereira

Srivicha Krudsood

Fe Espino

Harald Noedl

Brian Angus

Joerg-Peter Kleim

Kim Fletcher

Jhon Breton

Lon Chanthap

Jhonatan Jesus Alarcon Baldeon

Raul Chuquiyauri

John Breton

Viviana Wilches

Oscar Nolasco Cárdenas

Ivan D. Velez

Maria F. Villegas

Chaiado Namaik-Larp

Tran T. Hien

Cindy Chu

Dionicia Gamboa Vilela

Joseph Vinetz

Mitchel Guzmán

Paulo Manrique Valverde

Cletus O. Ugwuegbulam